Related references
Note: Only part of the references are listed.TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of β-catenin
Kefei Yuan et al.
CELL DEATH AND DIFFERENTIATION (2020)
MicroRNA-188-5p promotes apoptosis and inhibits cell proliferation of breast cancer cells via the MAPK signaling pathway by targeting Rap2c
Xinying Zhu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
High-throughput screening identified mitoxantrone to induce death of hepatocellular carcinoma cells with autophagy involvement
Bushan Xie et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Yes-Associated Protein and PDZ Binding Motif: A Critical Signaling Pathway in the Control of Human Pluripotent Stem Cells Self-Renewal and Differentiation
Jia Shi et al.
CELLULAR REPROGRAMMING (2020)
Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
Youn-Sang Jung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
ROS in cancer therapy: the bright side of the moon
Bruno Perillo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Autophagy and autophagy-related proteins in cancer
Xiaohua Li et al.
MOLECULAR CANCER (2020)
Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma
Ming Hong et al.
PHYTOMEDICINE (2020)
Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma
Manali Dimri et al.
CANCERS (2020)
The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
Haiyu Wang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Fucoidan Induces Apoptosis and Inhibits Proliferation of Hepatocellular Carcinoma via the p38 MAPK/ERK and PI3K/Akt Signal Pathways
Yifei Duan et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Role of p53 in the Regulation of Cellular Senescence
Mahmut Mijit et al.
BIOMOLECULES (2020)
Insights into Nanotherapeutic Strategies as an Impending Approach to Liver Cancer Treatment
Archu Singh et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy: The emerging role of non-viral risk factors
Wanying Li et al.
LIVER INTERNATIONAL (2020)
ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer
Gan Huang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Irradiated mesenchymal stem cells support stemness maintenance of hepatocellular carcinoma stem cells through Wnt/β-catenin signaling pathway
Jing Hou et al.
CELL AND BIOSCIENCE (2020)
The Wnt Signalling Pathway: A Tailored Target in Cancer
Malvina Koni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Metabolic rewiring in the promotion of cancer metastasis: mechanisms and therapeutic implications
Qinyao Wei et al.
ONCOGENE (2020)
New Therapeutic Options for Advanced Hepatocellular Carcinoma
Yu-Shui Ma et al.
CANCER CONTROL (2020)
Hepatic Hippo signaling inhibits development of hepatocellular carcinoma
Yuchen Liu et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2020)
Towards DNA-damage induced autophagy: A Boolean model of p53-induced cell fate mechanisms
Shantanu Gupta et al.
DNA REPAIR (2020)
Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinoma
Jie Zhang et al.
CELL AND BIOSCIENCE (2020)
Study on the hepatocellular carcinoma model with metastasis
Yu-Lin Lin et al.
GENES & DISEASES (2020)
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
Weiwei Tang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Hypoxia Activates SOX5/Wnt/β-Catenin Signaling by Suppressing MiR-338-3p in Gastric Cancer
Jing-jing Zheng et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)
A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy
Ajaybabu Pobbati et al.
THERANOSTICS (2020)
2-Ethoxystypandrone, a novel small-molecule STAT3 signaling inhibitor from Polygonum cuspidatum, inhibits cell growth and induces apoptosis of HCC cells and HCC Cancer stem cells
Wuguo Li et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Brivanib in combination with Notch3 silencing shows potent activity in tumour models
Catia Giovannini et al.
BRITISH JOURNAL OF CANCER (2019)
Key Role of Reactive Oxygen Species (ROS) in Indirubin Derivative-Induced Cell Death in Cutaneous T-Cell Lymphoma Cells
Marwa Y. Soltan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A selective c-Met and Trks inhibitor Indo5 suppresses hepatocellular carcinoma growth
Teng Luo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Morin enhances auranofin anticancer activity by up-regulation of DR4 and DR5 and modulation of Bcl-2 through reactive oxygen species generation in Hep3B human hepatocellular carcinoma cells
Hyun Hwang-Bo et al.
PHYTOTHERAPY RESEARCH (2019)
Autophagy: Dual Response in the Development of Hepatocellular Carcinoma
Hamza O. Yazdani et al.
CELLS (2019)
The role of telomeres and telomerase in cirrhosis and liver cancer
Jean-Charles Nault et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Immunomodulatory TGF-β Signaling in Hepatocellular Carcinoma
Jian Chen et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells
Florian P. Reiter et al.
CELLULAR ONCOLOGY (2019)
Liver Tissue Engineering: Challenges and Opportunities
Tarun Agarwal et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2019)
A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
R. K. Kelley et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)
Artemisinin suppresses hepatocellular carcinoma cell growth, migration and invasion by targeting cellular bioenergetics and Hippo-YAP signaling
Yujie Li et al.
ARCHIVES OF TOXICOLOGY (2019)
Prior hepatitis B virus infection as a co-factor of chronic hepatitis C patient survival after resection of hepatocellular carcinoma
Yutaka Midorikawa et al.
BMC GASTROENTEROLOGY (2019)
Targeted therapy for hepatocellular carcinoma: Challenges and opportunities
Shuzhen Chen et al.
CANCER LETTERS (2019)
Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies
Ali Alqahtani et al.
MEDICINA-LITHUANIA (2019)
Potent Activity of Composite Cyclin Dependent Kinase Inhibition against Hepatocellular Carcinoma
Yu-Yun Shao et al.
CANCERS (2019)
The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
Chin-Yap Loh et al.
CELLS (2019)
Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma
Jacopo Gavini et al.
CELL DEATH & DISEASE (2019)
Validation of Hepatocellular Carcinoma Experimental Models for TGF-β Promoting Tumor Progression
Serena Mancarella et al.
CANCERS (2019)
Koumine Promotes ROS Production to Suppress Hepatocellular Carcinoma Cell Proliferation Via NF-κB and ERK/p38 MAPK Signaling
Zhihang Yuan et al.
BIOMOLECULES (2019)
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
Vaishali Aggarwal et al.
BIOMOLECULES (2019)
Redox-Mediated Mechanism of Chemoresistance in Cancer Cells
Eun-Kyung Kim et al.
ANTIOXIDANTS (2019)
The Role of Angiogenesis in Hepatocellular Carcinoma
Michael A. Morse et al.
CLINICAL CANCER RESEARCH (2019)
Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma
Caiyan Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Intracellular sensing of viral genomes and viral evasion
Hyun-Cheol Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy
Po-Li Wei et al.
PLOS ONE (2019)
The Carcinogenic Role of the Notch Signaling Pathway in the Development of Hepatocellular Carcinoma
Qinfeng Huang et al.
JOURNAL OF CANCER (2019)
Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma
Zhili Ma et al.
THERANOSTICS (2019)
Epigenetics of hepatocellular carcinoma
Tan Boon Toh et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2019)
Role of Radiotherapy in the Treatment of Hepatocellular Carcinoma
Chien Pong Chen
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2019)
Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics
Rehmat Jan et al.
ADVANCED PHARMACEUTICAL BULLETIN (2019)
Developing TRAIL/TRAIL death receptor-based cancer therapies
Xun Yuan et al.
CANCER AND METASTASIS REVIEWS (2018)
TGF-beta 1 Promotes Hepatocellular Carcinoma Invasion and Metastasis via ERK Pathway-Mediated FGFR4 Expression
Jiawei Huang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma
Mohamed Bouattour et al.
HEPATOLOGY (2018)
Chemical and genetic inhibition of STAT3 sensitizes hepatocellular carcinoma cells to sorafenib induced cell death
Linna Xie et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Apoptosis: A Target for Anticancer Therapy
Claire M. Pfeffer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Modulation of the gamma-secretase activity as a therapy against human hepatocellular carcinoma
Yuqing Shen et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
EGF is highly expressed in hepatocellular carcinoma (HCC) and promotes motility of HCC cells via fibronectin
Zongcai Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
Yazhuo Zhang et al.
MOLECULAR CANCER (2018)
Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors
Yang Yang et al.
CELL DEATH & DISEASE (2018)
EGFR-PI3K-PDK1 pathway regulates YAP signaling in hepatocellular carcinoma: the mechanism and its implications in targeted therapy
Hongwei Xia et al.
CELL DEATH & DISEASE (2018)
A Review of Notch Processing with New insights into Ligand-independent Notch Signaling in T-Cells
Martin Peter Steinbuck et al.
FRONTIERS IN IMMUNOLOGY (2018)
MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?
Samy A. Azer
JOURNAL OF CLINICAL MEDICINE (2018)
YAP/TAZ Activation as a Target for Treating Metastatic Cancer
Janine S. A. Warren et al.
CANCERS (2018)
Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress
Xiaodong Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma
Roland Sonntag et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
Javier A. Garcia-Vilas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
Isabel Fabregat et al.
FRONTIERS IN ONCOLOGY (2018)
The Roles of Autophagy in Cancer
Chul Won Yun et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Hepatocellular carcinoma treatment: hurdles, advances and prospects
Ratna Kumari et al.
HEPATIC ONCOLOGY (2018)
Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2
Hongwei Lv et al.
NPJ PRECISION ONCOLOGY (2018)
The role of the Hedgehog signaling pathway in cancer: A comprehensive review
Ana Marija Skoda et al.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2018)
Autophagy pathway: Cellular and molecular mechanisms
Li Yu et al.
AUTOPHAGY (2018)
Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review
Saleh Daher et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2018)
Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma
Supritha G. Swamy et al.
TARGETED ONCOLOGY (2017)
Inhibition of STAT3 signaling pathway by ursolic acid suppresses growth of hepatocellular carcinoma
Tianshu Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1-Stat3
Chuan Xing Wu et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Hypoxia and aerobic metabolism adaptations of human endothelial cells
Agnieszka Koziel et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2017)
Hepatitis B virus infection and alcohol consumption
Ayako Iida-Ueno et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Increasing AR by HIF-2α inhibitor (PT-2385) overcomes the side-effects of sorafenib by suppressing hepatocellular carcinoma invasion via alteration of pSTAT3, pAKT and pERK signals
Junjie Xu et al.
CELL DEATH & DISEASE (2017)
Yes-associated protein: A novel molecular target for the diagnosis, treatment and prognosis of hepatocellular carcinoma (Review)
Liang Shan et al.
ONCOLOGY LETTERS (2017)
Hypoxia inducible factors in hepatocellular carcinoma
Chu Chen et al.
ONCOTARGET (2017)
Metabolomic applications in hepatocellular carcinoma: toward the exploration of therapeutics and diagnosis through small molecules
Jing Xie et al.
RSC ADVANCES (2017)
Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma
Wei Xu et al.
SCIENTIFIC REPORTS (2017)
Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells
Krishna S. Tummala et al.
CELL REPORTS (2017)
Huaier Restrains Proliferative and Migratory Potential of Hepatocellular Carcinoma Cells Partially Through Decreased Yes-Associated Protein 1
Liang Shan et al.
JOURNAL OF CANCER (2017)
The Injury-Related Activation of Hedgehog Signaling Pathway Modulates the Repair-Associated Inflammation in Liver Fibrosis
Xin Shen et al.
FRONTIERS IN IMMUNOLOGY (2017)
Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade
Jiaoyuan Jia et al.
PLOS ONE (2017)
Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in Mice
Kwang Hwa Jung et al.
CLINICAL CANCER RESEARCH (2017)
The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells
Farhad Seif et al.
CELL COMMUNICATION AND SIGNALING (2017)
Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives
Catia Giovannini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
Shubhasree Banerjee et al.
DRUGS (2017)
Auranofin, an inhibitor of thioredoxin reductase, induces apoptosis in hepatocellular carcinoma Hep3B cells by generation of reactive oxygen species
Hyun Hwang-Bo et al.
GENERAL PHYSIOLOGY AND BIOPHYSICS (2017)
EGFR Signaling in Liver Diseases
Karin Komposch et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Activation of apoptosis signalling pathways by reactive oxygen species
Maureen Redza-Dutordoir et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
HSP90 inhibits apoptosis and promotes growth by regulating HIF-1α abundance in hepatocellular carcinoma
Xin Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Role of epithelial to mesenchymal transition in hepatocellular carcinoma
Gianluigi Giannelli et al.
JOURNAL OF HEPATOLOGY (2016)
Preclinical Evaluation of AMG 337, a Highly Selective Small Molecule MET Inhibitor, in Hepatocellular Carcinoma
Zhiqiang Du et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment
Valery Vilchez et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
TGF-β Signaling from Receptors to Smads
Akiko Hata et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth
Yan-Yan Jia et al.
ONCOTARGET (2016)
Therapeutic Strategies in HCC: Radiation Modalities
R. Gallicchio et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling
Haiji Wang et al.
MEDICAL SCIENCE MONITOR (2016)
Notch Signaling in Cell-Cell Communication Pathways
Anna Bigas et al.
CURRENT STEM CELL REPORTS (2016)
Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma
Chi Man Tsang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell-like Behaviors Contributing to Disease Progression
Hiromitsu Hayashi et al.
CANCER RESEARCH (2015)
Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy
Xiaoyun Dai et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment
Xueru Mu et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Downregulation of Notch1 induces apoptosis and inhibits cell proliferation and metastasis in laryngeal squamous cell carcinoma
Meng-Yuan Dai et al.
ONCOLOGY REPORTS (2015)
Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway
Zhaojun Wan et al.
ONCOLOGY REPORTS (2015)
Transforming Growth Factor-Beta and Oxidative Stress Interplay: Implications in Tumorigenesis and Cancer Progression
Jelena Krstic et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target
Daniel Lin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells
Carolina Simioni et al.
ONCOTARGET (2015)
Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients
Maria Serova et al.
ONCOTARGET (2015)
MicroRNA-423-5p Promotes Autophagy in Cancer Cells and Is Increased in Serum From Hepatocarcinoma Patients Treated With Sorafenib
Paola Stiuso et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
HIF-1α pathway: role, regulation and intervention for cancer therapy
Georgina N. Masoud et al.
ACTA PHARMACEUTICA SINICA B (2015)
Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte
Carla Cicchini et al.
LIVER INTERNATIONAL (2015)
Influence of P53 on the radiotherapy response of hepatocellular carcinoma
Ana R. Gomes et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2015)
Control of oxidative stress in hepatocellular carcinoma: Helpful or harmful?
Akinobu Takaki et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
miR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met
Peyda Korhan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Nutlin-3 downregulates p53 phosphorylation on serine392 and induces apoptosis in hepatocellular carcinoma cells
Xinli Shi et al.
BMB REPORTS (2014)
Network Modeling of TGFβ Signaling in Hepatocellular Carcinoma Epithelial-to-Mesenchymal Transition Reveals Joint Sonic Hedgehog and Wnt Pathway Activation
Steven Nathaniel Steinway et al.
CANCER RESEARCH (2014)
The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment
Peixin Huang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
YAP activation is an early event and a potential therapeutic target in liver cancer development
Andrea Perra et al.
JOURNAL OF HEPATOLOGY (2014)
Hepatocellular carcinoma: targeting of oncogenic signaling networks in TRAIL resistant cancer cells
Sundas Fayyaz et al.
MOLECULAR BIOLOGY REPORTS (2014)
Signaling mechanisms of the epithelial-mesenchymal transition
David M. Gonzalez et al.
SCIENCE SIGNALING (2014)
Oxidative damage in the progression of chronic liver disease to hepatocellular carcinoma: An intricate pathway
Romilda Cardin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Hepatocellular carcinoma review: Current treatment, and evidence-based medicine
Ali Raza et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma
Dongjun Luo et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Overexpression of Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5 (LGR5) Represents a Typical Wnt/β-Catenin Pathway-Activated Hepatocellular Carcinoma
Kathryn Effendi et al.
LIVER CANCER (2014)
The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations
Xavier Bisteau et al.
CANCERS (2014)
STAT3 in hepatocellular carcinoma: new perspectives
Jasmin Svinka et al.
HEPATIC ONCOLOGY (2014)
Autophagy negatively regulates cancer cell proliferation via selectively targeting VPRBP
Bo-Shi Wang et al.
CLINICAL SCIENCE (2013)
Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
Virginia Hernandez-Gea et al.
GASTROENTEROLOGY (2013)
Hedgehog Signaling Pathway Regulates Autophagy in Human Hepatocellular Carcinoma Cells
Ying Wang et al.
HEPATOLOGY (2013)
Increased Apoptosis Induction in Hepatocellular Carcinoma by a Novel Tumor-Targeted TRAIL Fusion Protein Combined With Bortezomib
Kristin Wahl et al.
HEPATOLOGY (2013)
The beta-Catenin Destruction Complex
Jennifer L. Stamos et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Hedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF-A expression in hepatocellular carcinoma
Matthias Pinter et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2013)
Downregulation of the Notch signaling pathway inhibits hepatocellular carcinoma cell invasion by inactivation of matrix metalloproteinase-2 and-9 and vascular endothelial growth factor
Liang Zhou et al.
ONCOLOGY REPORTS (2012)
Signaling pathway/molecular targets and new targeted agents under development in hepatocellular carcinoma
Masatoshi Kudo
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Blockade of the sonic hedgehog pathway effectively inhibits the growth of hepatoma in mice: An in vivo study
Kuo-Shyang Jeng et al.
ONCOLOGY LETTERS (2012)
Emerging Signaling Pathways in Hepatocellular Carcinoma
Agrin Moeini et al.
LIVER CANCER (2012)
c-Met Represents a Potential Therapeutic Target for Personalized Treatment in Hepatocellular Carcinoma
Hanning You et al.
HEPATOLOGY (2011)
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
Marie Cargnello et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2011)
Expression of Sonic Hedgehog Signaling Components in Hepatocellular Carcinoma and Cyclopamine-induced Apoptosis Through Bcl-2 Downregulation In Vitro
Xi-lin Chen et al.
ARCHIVES OF MEDICAL RESEARCH (2010)
Molecular approaches to treatment of hepatocellular carcinoma
Anja Lachenmayer et al.
DIGESTIVE AND LIVER DISEASE (2010)
Reactive oxygen species in cancer
Geou-Yarh Liou et al.
FREE RADICAL RESEARCH (2010)
Inhibition of Transforming Growth Factor β Receptor I Kinase Blocks Hepatocellular Carcinoma Growth Through Neo-angiogenesis Regulation
Antonio Mazzocca et al.
HEPATOLOGY (2009)
Crosstalk of Notch with p53 and p63 in cancer growth control
G. Paolo Dotto
NATURE REVIEWS CANCER (2009)
Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells
Emilia Fransvea et al.
HEPATOLOGY (2008)
Molecular targeted therapies in hepatocellular carcinoma
Josep M. Llovet et al.
HEPATOLOGY (2008)
Genomics and signaling pathways in hepatocellular carcinoma
Augusto Villanueva et al.
SEMINARS IN LIVER DISEASE (2007)
VEGF in hepatocellular carcinoma and surrounding cirrhotic liver tissues
Muriel Mathonnet et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Hedgehog signaling in human hepatocellular carcinoma
MA Patil et al.
CANCER BIOLOGY & THERAPY (2006)
Angiogenesis and hepatocellular carcinoma
D Semela et al.
JOURNAL OF HEPATOLOGY (2004)
Comparisons of tumor suppressor p53, p21, and p16 gene therapy effects on glioblastoma tumorigenicity in situ
TJ Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Share Paper
